Lalonde, R L
Model-based drug development. [electronic resource]
- Clinical pharmacology and therapeutics Jul 2007
- 21-32 p. digital
Publication Type: Journal Article; Review
0009-9236
10.1038/sj.clpt.6100235 doi
Alzheimer Disease--drug therapy
Amines--pharmacology
Analgesics--pharmacology
Animals
Anticholesteremic Agents--pharmacology
Bridged Bicyclo Compounds, Heterocyclic--pharmacology
Caproates--pharmacology
Cholesterol--blood
Clinical Trials as Topic--legislation & jurisprudence
Cognition--drug effects
Computer Simulation
Cyclohexanecarboxylic Acids--pharmacology
Dose-Response Relationship, Drug
Drug Approval
Drug Design
Gabapentin
Glycoproteins--pharmacology
Guidelines as Topic
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology
Hypercholesterolemia--blood
Immunologic Factors--pharmacology
Meta-Analysis as Topic
Models, Biological
Models, Statistical
Muscarinic Agonists--pharmacology
Neuralgia, Postherpetic--drug therapy
Neutrophil Infiltration--drug effects
Oximes--pharmacology
Pharmacokinetics
Pharmacology
Reproducibility of Results
Research Design
Stroke--drug therapy
United States
United States Food and Drug Administration
gamma-Aminobutyric Acid--pharmacology